180 related articles for article (PubMed ID: 901736)
1. Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.
Frigo GM; Perucca E; Teggia-Droghi M; Gatti G; Mussini A; Salerno J
Br J Clin Pharmacol; 1977 Aug; 4(4):449-54. PubMed ID: 901736
[TBL] [Abstract][Full Text] [Related]
2. Serum quinidine levels after chronic administration of four different quinidine formulations.
Soeterboek AM; Van Thiel M; Eng C
J Int Med Res; 1976; 4(6):393-401. PubMed ID: 1027633
[TBL] [Abstract][Full Text] [Related]
3. Enteric coated quinidine compared to sustained release preparations during repeated administration.
Bakke OM; Aanderud L; Aslaksen A
Acta Med Scand; 1980; 207(3):183-7. PubMed ID: 7368984
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of quinidine in slow-release form. A comparison between two preparations containing quinidine bisulphate as the active constituent.
Regårdh CG; Johnsson G; Lundborg P; Perrson BA
Arzneimittelforschung; 1977; 27(9):1716-8. PubMed ID: 21671
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence of quinidine in two sustained-release preparations.
Garty M; Rachmel A; Ilfeld D; Sinai Y; Paz R
Isr J Med Sci; 1992 Jun; 28(6):357-61. PubMed ID: 1607272
[TBL] [Abstract][Full Text] [Related]
6. Comparative bioavailability characteristics of commercial quinidine polygalacturonate and sulfate tablets.
Dahl JR; Ueda CT; Meyers DG; Wulf BG
DICP; 1990; 24(7-8):685-8. PubMed ID: 2375136
[TBL] [Abstract][Full Text] [Related]
7. Comparative plasma concentrations of quinidine following administration of one intramuscular and three oral formulations to 13 human subjects.
Mason WD; Covinsky JO; Valentine JL; Kelly KL; Weddle OH; Martz BL
J Pharm Sci; 1976 Sep; 65(9):1325-9. PubMed ID: 966146
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of a commercial sustained-release quinidine tablet compared to oral quinidine solution.
Sawyer WT; Pulliam CC; Mattocks A; Foster J; Hadzija BW; Rosenthal HM
Biopharm Drug Dispos; 1982; 3(4):301-10. PubMed ID: 7159686
[TBL] [Abstract][Full Text] [Related]
9. Quinidine dosage, with special reference to an oral loading dose schedule.
Collste P; Nordlander R
Br J Clin Pharmacol; 1979 Mar; 7(3):293-7. PubMed ID: 427006
[TBL] [Abstract][Full Text] [Related]
10. Absolute quinidine bioavailability.
Ueda CT; Williamson BJ; Dzindzio BS
Clin Pharmacol Ther; 1976 Sep; 20(3):260-5. PubMed ID: 954347
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two long-acting forms of quinidine.
Leizorovicz A; Piolat C; Boissel JP; Sanchini B; Ferry S
Br J Clin Pharmacol; 1984 Jun; 17(6):729-34. PubMed ID: 6743467
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioavaiability of four commercial quinidine sulfate tablets.
Strum JD; Colaizzi JL; Jaffe JM; Martineau PC; Poust RI
J Pharm Sci; 1977 Apr; 66(4):539-42. PubMed ID: 576879
[TBL] [Abstract][Full Text] [Related]
13. Disposition kinetics of two oral forms of quinidine.
Mahon WA; Mayersohn M; Inaba T
Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):566-75. PubMed ID: 1277713
[TBL] [Abstract][Full Text] [Related]
14. [Relative bioavailability and influence of a quinidine retard-formulation on blood-pressure and ECG in healthy volunteers (author's transl)].
Knapp W; Lechleitner P
Arzneimittelforschung; 1981; 31(9):1482-6. PubMed ID: 7197960
[TBL] [Abstract][Full Text] [Related]
15. Comparative bioavailability study of three sustained release quinidine formulations.
Mahon WA; Leeder JS; Brill-Edwards MM; Correia J; MacLeod SM
Clin Pharmacokinet; 1987 Aug; 13(2):118-24. PubMed ID: 3621768
[TBL] [Abstract][Full Text] [Related]
16. Relative bioavailability of three commercial quinidine dosage forms.
Sirois G; Eshaque M; Chabot M
Biopharm Drug Dispos; 1980; 1(4):167-77. PubMed ID: 7448345
[TBL] [Abstract][Full Text] [Related]
17. Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay to assess quinidine pharmacokinetics.
Bottorff MB; Lalonde RL; Straughn AB
Biopharm Drug Dispos; 1987; 8(3):213-21. PubMed ID: 3297181
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.
Greenblatt DJ; Pfeifer HJ; Ochs HR; Franke K; MacLaughlin DS; Smith TW; Koch-Weser J
J Pharmacol Exp Ther; 1977 Aug; 202(2):365-78. PubMed ID: 577934
[No Abstract] [Full Text] [Related]
19. Bioavailability of three commercial sustained-release tablets of quinidine in maintenance therapy.
Huynh-Ngoc T; Chabot M; Sirois G
J Pharm Sci; 1978 Oct; 67(10):1456-9. PubMed ID: 702302
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of two manufacturers' sustained-release quinidine gluconate tablets at steady state.
Zinny MA; Taggart WV
Clin Ther; 1984; 7(1):22-7. PubMed ID: 6518461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
